Haleon plc

NYSE:HLN

Drug Manufacturers - Specialty & Generic

Healthcare
$9.08 +0.96%

+$0.08 today

Market cap
$39.85B
Beta
0.25
P/E (TTM)
29.2
EPS (TTM)
$0.11
Dividend yield
2.13%
52W Low $8.65High $11.28

Volume 19.46M

Average 8.79M

HLN Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Haleon plcNYSE: HLN

Operating Margin · Q4 FY2025 · quarter ended Dec 2025

Operating margin widens to 22.7%

Operating margin was 22.7% in Q4 FY2025, up 3.6 pp from a year earlier. On a trailing-twelve-month basis it was 21.6%. Over 3 fiscal years it widened by 5.1 pp.

Context

  • Operating margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether operating margin reaches the consensus estimate from 12 analysts of 26.1% for the fiscal year ending Dec 2026, up from 21.9% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterDec 2025
22.7%— QoQ
Last fiscal yearDec 2025
21.9%+2.2 pp YoY
LTMJun 2025
21.6%— YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.6 pp+4.0 pp+0.4 pp
1 year+2.2 pp+4.2 pp+2.0 pp
3 years+5.1 pp+5.5 pp+0.4 pp
5 years+7.2 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
21.9%
Year-over-year change
+2.2pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How HLN compares with its peers on the latest reported figures

  • HLN's LTM Jun 2025 operating margin of 21.6% is the highest of the 6 companies compared; the peer median is 19.9%.
  • Over three fiscal years its change of +5.1 pp compares with a peer median of +3.6 pp.
HLN Competitors Peer median
Operating Margin for HLN and competitors
Company Period LTM level YoY 3-year change
HLNHaleon plcLTM Jun 202521.6% —+5.1 pp
GSKGSK plcLTM Jun 202620.7% +4.5 pp+3.6 pp
CLColgate-Palmolive CompanyLTM Sep 202620.5% -1.1 pp-3.7 pp
KVUEKenvue Inc.LTM Sep 202619.9% +4.1 pp-0.0 pp
CHDChurch & Dwight Co., Inc.LTM Sep 202618.0% +0.6 pp+6.3 pp
PRGOPerrigo Company plcLTM Jun 20265.2% -1.4 pp+6.3 pp
Peer median (excluding HLN) 19.9%+0.6 pp+3.6 pp

Competitors are the stored peer set for HLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

GBP
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue9.55B10.86B11.3B11.23B11.03B
Cost of Revenue3.6B4.28B4.34B4.29B3.83B
Gross Profit5.95B6.58B6.96B6.95B6.99B
Gross Margin62.3%60.6%61.6%61.9%63.3%
Research & Development257M300M311M298M308.1M
Selling, General & Admin3.79B4.04B4.29B4.33B4.36B
Operating Expenses4.31B4.75B4.97B4.74B4.43B
Depreciation & Amortization268M287M309M196M352.11M
EBITDA2.21B2.18B2.35B2.51B2.88B
EBITDA Margin23.2%20.1%20.8%22.4%26.1%
Operating Income1.64B1.83B2B2.21B2.41B
Operating Margin17.2%16.8%17.7%19.6%21.9%
Interest Income13M68.98M14M55M76.29M
Interest Expense16M347.36M414M394M332.55M
Other Income / Expenses(2M)(207M)(368M)(296M)(260M)
Income Before Tax1.64B1.62B1.63B1.91B2.15B
Pre-Tax Margin17.1%14.9%14.4%17.0%19.5%
Income Tax Expense197M499M517M435M461.66M
Net Income1.39B1.06B1.05B1.44B1.63B
Net Margin14.6%9.8%9.3%12.8%14.8%
EPS (Basic)0.300.240.240.320.36
EPS (Diluted)0.300.240.240.320.36
Weighted Avg Shares4.62B4.62B4.63B4.57B4.48B
Weighted Avg Shares (Diluted)4.62B4.62B4.63B4.59B4.51B

Haleon plc

NYSE:HLN

Intrinsic Alpha fair value

Locked

Current Price

$9.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.